In addition to potentially promoting HCC tumorigenesis, the two upregulated ncRNAs, especially the lncRNA DUXAP10, in the exosome of HCC patients may also be potential diagnostic biomarkers for HCC. The gene discussed is DUXAP10; the disease is hepatocellular carcinoma.